Reports
Reports
Analysts’ Viewpoint
Smart implantable pumps are widely used to treat pain & spasticity, pulmonary arterial hypertension, and heart failure. Rise in admission of coronavirus patients in intensive care units (ICU) increased the demand for these pumps during the peak of the COVID-19 pandemic.
Technological advances in implantable pumps, such as less risky and more sophisticated products, are expected to drive the industry in the near future. Increase in government support in terms of reimbursement or investments in research activities is projected to be a major market trigger in the next few years.
Key companies are carrying out mechanical improvements in implantable drug pumps and technological advancements to fuel business expansion.
Smart implantable pumps are small medical devices that are used to administer medications in a consistent dose. Smart pumps are intended to notify a user when there is a risk of an adverse drug interaction or when the pump's parameters are set outside of specified safety limits.
Implantable pumps are made up of a reservoir, which is mounted subcutaneously and connected to the pump's intrathecal space via a catheter.
Implantable drug pump directs liquid medication to a specific area of the body via a thin flexible tube or a catheter. It delivers medication and nutrients in precise amounts.
The pump is available for treatment in all medical facilities. It is operated by professional medical practitioners who understand how to program the duration and rate of fluid delivery. Thus, rise in prevalence of chronic pain and spasticity is fueling industry growth.
Technological advancements have played a key role in driving the smart implantable pumps market in the past few years. The trend is expected to continue in the next few years.
Hence, manufacturers are focusing on developing innovative products to gain a competitive edge over other players. Introduction of advanced implantable pumps has reduced mortality as well as morbidity rates. This is propelling the demand for these pumps.
Smart implantable pumps have several advantages over traditional delivery systems (syringes/pens/syringes). These pumps manage the drug site, minimize possible side effects, and help improve the quality of life.
These devices are patient-friendly, as the associated regimen is usually less burdensome with safety measures than pills or injections. Therefore, advantages of these devices over conventional systems are likely to augment business development.
In terms of type, the global market has been bifurcated into perfusion pumps and micro pumps. The perfusion pumps segment accounted for the largest global smart implantable pumps market share in 2021.
Development of safe and efficacious perfusion systems, introduction of technically advanced implantable infusion pumps, and rise in adoption of these products are projected to propel the segment in the next few years.
Based on application, the global smart implantable pumps industry has been split into pain & spasticity and cardiovascular. Cardiovascular was the dominant segment in 2021 due to the rise in prevalence of cardiovascular diseases across the globe. Increase in incidence of heart failure and shortage of heart donors are expected to augment the segment during the forecast period.
In terms of end-user, the market segmentation entails hospitals, ambulatory surgical centers, and others. The hospitals segment held prominent global smart implantable pumps market share in 2021. Expanding base of hospitals and increase in number of hospital visits due to rise in prevalence of chronic illnesses such as pain and spasticity among hospitalized patients are the major factors driving the segment.
Furthermore, surge in preference for implantable infusion pumps and availability of different types of the device at hospitals are likely to fuel the segment during the forecast period.
North America is projected to be a highly attractive region for these devices during the forecast period. The market in the region is driven by large number of implantation procedures, high rate of adoption of new technologically advanced implantable medical devices, significant healthcare expenditure, and increase in research activities.
Europe is likely to record significant market progress during the forecast period. Rise in demand for smart pumps can be ascribed to the increase in incidence of chronic diseases and favorable reimbursement policies in the region.
Asia Pacific is likely to witness substantial market expansion in the next few years. Improvement in healthcare infrastructure, rise in awareness, and increase in purchasing power of the people are augmenting the market in the region.
Surge in patient base suffering from various chronic diseases due to changes in lifestyle is projected to drive market statistics in Asia Pacific during the forecast period.
The global market is fragmented, with the presence of large number leading players. Key players operating in the industry are Abbott, Baxter, Cognos Therapeutics, Inc., Flowonix Medical, Inc., Medtronic, Terumo Europe NV, Intarcia Therapeutics, Inc., Fresenius Kabi (Ivenix), and tricumed Medizintechnik GmbH.
These players are adopting growth strategies such as new product development, product launches, product approval, agreement, partnerships, and mergers to increase their market footprint.
The market report profiles leading players based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2021 |
US$ 1.8 Bn |
|
Forecast Value in 2031 |
More than US$ 3.8 Bn |
|
CAGR - 2022–2031 |
7.5% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
.Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
The market was valued at US$ 1.8 Bn in 2021
It is projected to reach more than US$ 3.8 Bn by 2031
The market grew at a CAGR of 9.5% from 2017 to 2021
The industry is anticipated to grow at a CAGR of 7.5% from 2022 to 2031
The perfusion pumps segment held more than 60.0% share in 2021
North America is expected to account for the largest share from 2022 to 2031
Abbott, Baxter, Cognos Therapeutics, Inc., Flowonix Medical, Inc., Medtronic, Terumo Europe NV, Intarcia Therapeutics, Inc., Fresenius Kabi (Ivenix), and Tricumed Medizintechnik GmbH.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Smart Implantable Pumps Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Smart Implantable Pumps Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Regulatory Scenario by Region/globally
5.3. Overview of Adjacent Market
5.4. Types of Drugs Delivered by Perfusion Pump and Micro Pump
5.5. Covid-19 Impact Analysis
6. Global Smart Implantable Pumps Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Perfusion Pumps
6.3.2. Micro Pumps
6.4. Market Attractiveness Analysis, by Type
7. Global Smart Implantable Pumps Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Pain & Spasticity
7.3.2. Cardiovascular
7.4. Market Attractiveness Analysis, by Application
8. Global Smart Implantable Pumps Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Smart Implantable Pumps Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Smart Implantable Pumps Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2031
10.2.1. Perfusion Pumps
10.2.2. Micro Pumps
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Pain & Spasticity
10.3.2. Cardiovascular
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Smart Implantable Pumps Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Perfusion Pumps
11.2.2. Micro Pumps
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Pain & Spasticity
11.3.2. Cardiovascular
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Smart Implantable Pumps Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Perfusion Pumps
12.2.2. Micro Pumps
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Pain & Spasticity
12.3.2. Cardiovascular
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Smart Implantable Pumps Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Perfusion Pumps
13.2.2. Micro Pumps
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Pain & Spasticity
13.3.2. Cardiovascular
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Smart Implantable Pumps Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Perfusion Pumps
14.2.2. Micro Pumps
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Pain & Spasticity
14.3.2. Cardiovascular
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Abbott
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Baxter
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Cognos Therapeutics, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Flowonix Medical, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Medtronic
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Terumo Europe NV
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Tricumed Medizintechnik GmbH
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Intarcia Therapeutics, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Fresenius Kabi (Ivenix)
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
List of Tables
Table 01: Global Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Type, 2017‒2031
Table 02: Smart Implantable Pumps Market Value (US$ Mn) Forecast, by 2017‒2031, by Perfusion Pumps
Table 03: Smart Implantable Pumps Market Value (US$ Mn) Forecast, by 2017‒2031, by Micro Pumps
Table 04: Global Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Smart Implantable Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 08: North America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Type, 2017‒2031
Table 09: North America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Perfusion Pumps, 2017‒2031
Table 10: North America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Micro Pumps, 2017‒2031
Table 11: North America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: North America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Europe Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Type, 2017‒2031
Table 15: Europe Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Perfusion Pumps, 2017‒2031
Table 16: Europe Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Micro Pumps, 2017‒2031
Table 17: Europe Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Europe Smart Implantable Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Asia Pacific Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Asia Pacific Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Type, 2017‒2031
Table 21: Asia Pacific Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Perfusion Pumps, 2017‒2031
Table 22: Asia Pacific Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Micro Pumps, 2017‒2031
Table 23: Asia Pacific Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Asia Pacific Smart Implantable Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Type, 2017‒2031
Table 27: Latin America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Perfusion Pumps, 2017‒2031
Table 28: Latin America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Micro Pumps, 2017‒2031
Table 29: Latin America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Latin America Smart Implantable Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 31: Middle East & Africa Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East & Africa Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Type, 2017‒2031
Table 33: Middle East & Africa Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Perfusion Pumps, 2017‒2031
Table 34: Middle East & Africa Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Micro Pumps, 2017‒2031
Table 35: Middle East & Africa Smart Implantable Pumps Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 36: Middle East & Africa Smart Implantable Pumps Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Smart Implantable Pumps Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Smart Implantable Pumps Market Value Share, by Type, 2021
Figure 03: Smart Implantable Pumps Market Value Share, by Application, 2021
Figure 04: Smart Implantable Pumps Market Value Share, by End-user 2021
Figure 05: Global Smart Implantable Pumps Market Value Share Analysis, by Type, 2021 and 2031
Figure 06: Global Smart Implantable Pumps Market Attractiveness Analysis, by Type, 2022–2031
Figure 07: Global Smart Implantable Pumps Market Value (US$ Mn), by Perfusion Pumps, 2017‒2031
Figure 08: Global Smart Implantable Pumps Market Value (US$ Mn), by Micro Pumps, 2017‒2031
Figure 09: Global Smart Implantable Pumps Market Value Share Analysis, by Application, 2021 and 2031
Figure 10: Global Smart Implantable Pumps Market Attractiveness Analysis, by Application, 2022–2031
Figure 11: Global Smart Implantable Pumps Market Revenue (US$ Mn), by Pain & Spasticity, 2017–2031
Figure 12: Global Smart Implantable Pumps Market Revenue (US$ Mn), by Cardiovascular, 2017–2031
Figure 13: Global Smart Implantable Pumps Market Value Share Analysis, by End-user 2021 and 2031
Figure 14: Global Smart Implantable Pumps Market Attractiveness Analysis, by End-user 2022–2031
Figure 15: Global Smart Implantable Pumps Market Revenue (US$ Mn), by Hospital, 2017–2031
Figure 16: Global Smart Implantable Pumps Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 17: Global Smart Implantable Pumps Market Revenue (US$ Mn), by Others, 2017–2031
Figure 18: Global Smart Implantable Pumps Market Value Share Analysis, by Region, 2021 and 2031
Figure 19: Global Smart Implantable Pumps Market Attractiveness Analysis, by Region, 2022–2031
Figure 20: North America Smart Implantable Pumps Market Value (US$ Mn) Forecast, 2017–2031
Figure 21: North America Smart Implantable Pumps Market Value Share Analysis, by Country, 2021 and 2031
Figure 22: North America Smart Implantable Pumps Market Attractiveness Analysis, by Country, 2022–2031
Figure 23: North America Smart Implantable Pumps Market Value Share Analysis, by Type, 2021 and 2031
Figure 24: North America Smart Implantable Pumps Market Attractiveness Analysis, by Type, 2022–2031
Figure 25: North America Smart Implantable Pumps Market Value Share Analysis, by Application, 2021 and 2031
Figure 26: North America Smart Implantable Pumps Market Attractiveness Analysis, by Application, 2022–2031
Figure 27: North America Smart Implantable Pumps Market Value Share Analysis, by End-user 2021 and 2031
Figure 28: North America Smart Implantable Pumps Market Attractiveness Analysis, by End-user 2022–2031
Figure 29: Europe Smart Implantable Pumps Market Value (US$ Mn) Forecast, 2017–2031
Figure 30: Europe Smart Implantable Pumps Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 31: Europe Smart Implantable Pumps Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 32: Europe Smart Implantable Pumps Market Value Share Analysis, by Type, 2021 and 2031
Figure 33: Europe Smart Implantable Pumps Market Attractiveness Analysis, by Type, 2022–2031
Figure 34: Europe Smart Implantable Pumps Market Value Share Analysis, by Application, 2021 and 2031
Figure 35: Europe Smart Implantable Pumps Market Attractiveness Analysis, by Application, 2022–2031
Figure 36: Europe Smart Implantable Pumps Market Value Share Analysis, by End-user 2021 and 2031
Figure 37: Europe Smart Implantable Pumps Market Attractiveness Analysis, by End-user 2022–2031
Figure 38: Asia Pacific Smart Implantable Pumps Market Value (US$ Mn) Forecast, 2017–2031
Figure 39: Asia Pacific Smart Implantable Pumps Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 40: Asia Pacific Smart Implantable Pumps Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 41: Asia Pacific Smart Implantable Pumps Market Value Share Analysis, by Type, 2021 and 2031
Figure 42: Asia Pacific Smart Implantable Pumps Market Attractiveness Analysis, by Type, 2022–2031
Figure 43: Asia Pacific Smart Implantable Pumps Market Value Share Analysis, by Application, 2021 and 2031
Figure 44: Asia Pacific Smart Implantable Pumps Market Value Share Analysis, by End-user 2021 and 2031
Figure 45: Asia Pacific Smart Implantable Pumps Market Attractiveness Analysis, by End-user 2022–2031
Figure 46: Asia Pacific Smart Implantable Pumps Market Attractiveness Analysis, by Application, 2022–2031
Figure 47: Latin America Smart Implantable Pumps Market Value (US$ Mn) Forecast, 2017–2031
Figure 48: Latin America Smart Implantable Pumps Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 49: Latin America Smart Implantable Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 50: Latin America Smart Implantable Pumps Market Value Share Analysis, by Type, 2021 and 2031
Figure 51: Latin America Smart Implantable Pumps Market Attractiveness Analysis, by Type, 2022–2031
Figure 52: Latin America Smart Implantable Pumps Market Value Share Analysis, by Application, 2021 and 2031
Figure 53: Latin America Smart Implantable Pumps Market Attractiveness Analysis, by Application, 2022–2031
Figure 54: Latin America Smart Implantable Pumps Market Value Share Analysis, by End-user 2022–2031
Figure 55: Latin America Smart Implantable Pumps Market Attractiveness Analysis, by End-user, 2022–2031
Figure 56: Middle East & Africa Smart Implantable Pumps Market Value (US$ Mn) Forecast, 2017–2031
Figure 57: Middle East & Africa Smart Implantable Pumps Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 58: Middle East & Africa Smart Implantable Pumps Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
Figure 59: Middle East & Africa Smart Implantable Pumps Market Value Share Analysis, by Type, 2021 and 2031
Figure 60: Middle East & Africa Smart Implantable Pumps Market Attractiveness Analysis, by Type, 2022–2031
Figure 61: Middle East & Africa Smart Implantable Pumps Market Value Share Analysis, by Application, 2021 and 2031
Figure 62: Middle East & Africa Smart Implantable Pumps Market Attractiveness Analysis, by Application, 2022–2031
Figure 63: Middle East & Africa Smart Implantable Pumps Market Value Share Analysis, by End-user 2022–2031
Figure 64: Middle East & Africa Smart Implantable Pumps Market Attractiveness Analysis, by End-user, 2022–2031
Figure 65: Company Share Analysis, 2021
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Smart Implantable Pumps Market